Roth Capital Upgrades Tilray Brands to Buy, Maintains Price Target to $10
4/2/2026
Impact: 60
Healthcare
Roth Capital analyst Bill Kirk has upgraded Tilray Brands (NASDAQ: TLRY) from a Neutral rating to a Buy rating. The price target for the stock remains unchanged at $10.
AI summary, not financial advice
Share: